{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T18:37:51Z","timestamp":1773167871181,"version":"3.50.1"},"publisher-location":"Chichester, UK","reference-count":94,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd004863.pub3","type":"reference-entry","created":{"date-parts":[[2012,9,4]],"date-time":"2012-09-04T22:04:06Z","timestamp":1346796246000},"source":"Crossref","is-referenced-by-count":20,"title":["Early erythropoietin for preventing red blood cell transfusion in preterm and\/or low birth weight infants"],"prefix":"10.1002","author":[{"given":"Arne","family":"Ohlsson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjay M","family":"Aher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,9,12]]},"reference":[{"key":"10.1002\/14651858.CD004863.pub3-BIB1|cit1","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1442-200x.2005.02007.x","article-title":"Recombinant human erythropoietin therapy in low-birthweight preterm infants: a prospective controlled study","volume":"47","author":"Arif","year":"2005","journal-title":"Pediatrics International"},{"key":"10.1002\/14651858.CD004863.pub3-BIB2|cit2","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1093\/tropej\/48.4.227","article-title":"A comparison of high versus low dose recombinant human erythropoietin versus blood transfusion in the management of anaemia of prematurity in a developing country","volume":"48","author":"Avent","year":"2002","journal-title":"Journal of Tropical Pediatrics"},{"key":"10.1002\/14651858.CD004863.pub3-BIB3|cit3","doi-asserted-by":"crossref","first-page":"e635","DOI":"10.1542\/peds.2005-3186","article-title":"Erythropoietin concentrations and neurodevelopment outcome in preterm infants","volume":"118","author":"Bierer","year":"2006","journal-title":"Pediatrics"},{"key":"10.1002\/14651858.CD004863.pub3-BIB4|cit4","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0022-3476(05)82552-1","article-title":"Effect of high doses of human recombinant erythropoietin on the need for blood transfusions in preterm infants","volume":"121","author":"Carnielli","year":"1992","journal-title":"Journal of Pediatrics"},{"key":"10.1002\/14651858.CD004863.pub3-BIB5|cit5","doi-asserted-by":"crossref","first-page":"F44","DOI":"10.1136\/fn.79.1.F44","article-title":"Iron supplementation enhances response to high doses of recombinant human erythropoietin in preterm infants","volume":"79","author":"Carnielli","year":"1998","journal-title":"Archieves of Disease in Childhood Fetal Neonatal Edition"},{"key":"10.1002\/14651858.CD004863.pub3-BIB6|cit6","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF02886482","article-title":"Preventive effects of different dosages of recombinant human erythropoietin on anemia of premature infants","volume":"18","author":"Chang","year":"1998","journal-title":"Journal of Tongji Medical University"},{"key":"10.1002\/14651858.CD004863.pub3-BIB7|cit7","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1542\/peds.2007-2591","article-title":"An approach to using recombinant erythropoietin for neuroprotection in very preterm infants","volume":"122","author":"Fauch\u00e8re","year":"2008","journal-title":"Pediatrics"},{"key":"10.1002\/14651858.CD004863.pub3-BIB8|cit8","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1160\/TH04-02-0093","article-title":"Changes in thrombopoiesis and platelet reactivity in extremely low birth weight infants undergoing erythropoietin therapy for treatment of anaemia of prematurity","volume":"93","author":"Haiden","year":"2005","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1002\/14651858.CD004863.pub3-BIB9|cit9","first-page":"586","article-title":"Early use of recombinant human erythropoietin promotes neurobehavioral development in preterm infants","volume":"10","author":"He","year":"2008","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi"},{"key":"10.1002\/14651858.CD004863.pub3-BIB10|cit10","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1007\/s12098-008-0225-0","article-title":"Effects of early human recombinant erythropoietin therapy on the transfusion in healthy preterm infants","volume":"75","author":"Khatami","year":"2008","journal-title":"Indian Journal of Pediatrics"},{"key":"10.1002\/14651858.CD004863.pub3-BIB11|cit11","first-page":"739","article-title":"Evaluation of treatment results for anemia of prematurity treated with various doses of human recombinant erythropoietin","volume":"70","author":"Lauterbach","year":"1995","journal-title":"Pediatria Polska"},{"key":"10.1002\/14651858.CD004863.pub3-BIB12|cit12","first-page":"191","article-title":"Efficacy of early erythropoietin use in critically ill very-low-birth-weight premature newborn infants: controlled clinical trial","volume":"43","author":"Lima-Roogel","year":"1998","journal-title":"Sangre"},{"key":"10.1002\/14651858.CD004863.pub3-BIB13|cit13","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1056\/NEJM199404283301701","article-title":"The effect of epoetin beta (recombinant human erythropoietin) on the need for transfusion in very-low-birth-weight infants. European Multicentre Erythropoietin Study Group","volume":"330","author":"Maier","year":"1994","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD004863.pub3-BIB14|cit14","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1067\/mpd.2002.124309","article-title":"Early treatment with erythropoietin beta ameliorates anemia and reduces transfusion requirements in infants with birth weights below 1000 g","volume":"141","author":"Maier","year":"2002","journal-title":"Journal of Pediatrics"},{"key":"10.1002\/14651858.CD004863.pub3-BIB15|cit15","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/stem.150359","article-title":"The effect of recombinant human erythropoietin on circulating hematopoietic progenitor cells in anemic premature infants","volume":"15","author":"Meister","year":"1997","journal-title":"Stem Cells"},{"key":"10.1002\/14651858.CD004863.pub3-BIB16|cit16","doi-asserted-by":"crossref","first-page":"F41","DOI":"10.1136\/fn.88.1.F41","article-title":"Recombinant erythropoietin and blood transfusion in selected infants","volume":"88","author":"Meyer","year":"2003","journal-title":"Archieves of Disease in Childhood Fetal Neonatal Edition"},{"key":"10.1002\/14651858.CD004863.pub3-BIB17|cit17","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1159\/000419541","article-title":"Efficacy and safety of recombinant human erythropoietin to prevent the anemias of prematurity. European Randomized Multicenter Trial","volume":"88","author":"Obladen","year":"1991","journal-title":"Contributions to Nephrology"},{"key":"10.1002\/14651858.CD004863.pub3-BIB18|cit18","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0022-3476(95)70462-0","article-title":"Efficacy and cost analysis of treating very low birth weight infants with erythropoietin during their first two weeks of life: a randomized, placebo-controlled trial","volume":"126","author":"Ohls","year":"1995","journal-title":"Journal of Pediatrics"},{"key":"10.1002\/14651858.CD004863.pub3-BIB19|cit19","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0022-3476(97)70089-1","article-title":"The effect of erythropoietin on the transfusion requirements of preterm infants weighing 750 grams or less: a randomized, double blind, placebo-controlled study","volume":"131","author":"Ohls","year":"1997","journal-title":"Journal of Pediatrics"},{"key":"10.1002\/14651858.CD004863.pub3-BIB20|cit20","first-page":"291A","article-title":"Neurodevelopmental outcome and growth at 18-22 months in extremely low birth weight infants treated with early erythropoietin","volume":"51","author":"Ehrenkranz","year":"2002","journal-title":"Pediatric Research"},{"key":"10.1002\/14651858.CD004863.pub3-BIB21|cit21","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1542\/peds.2003-1129-L","article-title":"Neurodevelopmental outcome and growth at 18 to 22 months' corrected age in extremely low birth weight infants treated with early erythropoietin and iron","volume":"114","author":"Ohls","year":"2004","journal-title":"Pediatrics"},{"key":"10.1002\/14651858.CD004863.pub3-BIB22|cit22","doi-asserted-by":"crossref","first-page":"216 A","DOI":"10.1203\/00006450-199904020-01285","article-title":"A multicenter randomized double-masked placebo-controlled trial of early erythropoietin and iron administration to preterm infants","volume":"45","author":"Ohls","year":"1999","journal-title":"Pediatric Research"},{"key":"10.1002\/14651858.CD004863.pub3-BIB23|cit23","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1542\/peds.108.4.934","article-title":"Effects of early erythropoietin therapy on the transfusion requirements of preterm infants below 1250 grams birth weight: a multicenter, randomized, controlled trial","volume":"108","author":"Ohls","year":"2001","journal-title":"Pediatrics"},{"key":"10.1002\/14651858.CD004863.pub3-BIB24|cit24","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1542\/peds.108.4.934","article-title":"Effects of early erythropoietin therapy on the transfusion requirements of preterm infants below 1250 grams birth weight: a multicenter, randomized, controlled trial","volume":"108","author":"Ohls","year":"2001","journal-title":"Pediatrics"},{"key":"10.1002\/14651858.CD004863.pub3-BIB25|cit25","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/PL00008390","article-title":"Do recombinant human erythropoietin and iron supplementation increase the risk of retinopathy of prematurity?","volume":"159","author":"Romagnoli","year":"2000","journal-title":"European Journal of Pediatrics"},{"key":"10.1002\/14651858.CD004863.pub3-BIB26|cit26","first-page":"1313","article-title":"Early erythropoietin use for the prevention of anemia in infant premature","volume":"128","author":"Salvado","year":"2000","journal-title":"Revista Medica de Chile"},{"key":"10.1002\/14651858.CD004863.pub3-BIB27|cit27","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1203\/00006450-199311000-00022","article-title":"In which neonates does early recombinant human eryhtropoietin treatment prevent anemia of prematurity? Results of a randomized, controlled study","volume":"34","author":"Soubasi","year":"1993","journal-title":"Pediatric Research"},{"key":"10.1002\/14651858.CD004863.pub3-BIB28|cit28","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0022-3476(95)70313-6","article-title":"Follow-up of very low birth weight infants after erythropoietin treatment to prevent anemia of prematurity","volume":"127","author":"Soubasi","year":"1995","journal-title":"Journal of Pediatrics"},{"key":"10.1002\/14651858.CD004863.pub3-BIB29|cit29","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1159\/000014280","article-title":"Use of erythropoietin and its effects on blood lactate and 2,3-diphosphoglycerate in premature neonates","volume":"78","author":"Soubasi","year":"2000","journal-title":"Biology of the Neonate"},{"key":"10.1002\/14651858.CD004863.pub3-BIB30|cit30","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1046\/j.1440-1754.2001.00667.x","article-title":"Effect of recombinant human erythropoietin on transfusion needs in preterm infants","volume":"37","author":"Yeo","year":"2001","journal-title":"Journal of Paediatrics and Child Health"},{"key":"10.1002\/14651858.CD004863.pub3-BIB31|cit31","first-page":"287","article-title":"Efficacy of erythropoietin in premature infants","volume":"23","author":"Amin","year":"2002","journal-title":"Saudi Medical Journal"},{"key":"10.1002\/14651858.CD004863.pub3-BIB32|cit32","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1542\/peds.104.2.210","article-title":"Comparison between two and five doses a week of recombinant erythropoietin for anemia of prematurity: a randomized trial","volume":"104","author":"Brown","year":"1999","journal-title":"Pediatrics"},{"key":"10.1002\/14651858.CD004863.pub3-BIB33|cit33","first-page":"310A","article-title":"Cost effective use of recombinant erythropoietin (HuEPO) in very low birth weight (VLBW) infants for improved clinical outcomes","volume":"51","author":"Fearing","year":"2002","journal-title":"Pediatric Research"},{"key":"10.1002\/14651858.CD004863.pub3-BIB34|cit34","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1542\/peds.2006-1113","article-title":"Effects of a combined therapy of erythropoietin, iron, folate, and vitamin B12 on the transfusion requirements of extremely low birth weight infants","volume":"118","author":"Haiden","year":"2006","journal-title":"Pediatrics"},{"key":"10.1002\/14651858.CD004863.pub3-BIB35|cit35","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1542\/peds.2005-2475","article-title":"A randomized, controlled trial of the effects of adding vitamin B12 and folate to erythropoietin for the treatment of anemia of prematurity","volume":"118","author":"Haiden","year":"2006","journal-title":"Pediatrics"},{"key":"10.1002\/14651858.CD004863.pub3-BIB36|cit36","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1542\/peds.2007-2711","article-title":"A phase I\/II trial of high-dose erythropoietin in extremely low birth weight infants: pharmacokinetics and safety","volume":"122","author":"Juul","year":"2008","journal-title":"Pediatrics"},{"key":"10.1002\/14651858.CD004863.pub3-BIB37|cit37","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1651-2227.2007.00101.x","article-title":"Effects of erythropoietin on erythrocyte deformability in non-transfused preterm infants","volume":"96","author":"Klipp","year":"2007","journal-title":"Acta Paediatrica"},{"key":"10.1002\/14651858.CD004863.pub3-BIB38|cit38","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1600-0609.1999.tb01119.x","article-title":"Effect of recombinant human erythropoietin in preterm infants","volume":"63","author":"Krallis","year":"1999","journal-title":"European Journal of Haematology"},{"key":"10.1002\/14651858.CD004863.pub3-BIB39|cit39","series-title":"Pediatric Academic Societies' Annual Meeting","first-page":"E","article-title":"Randomized controlled trial on the effectiveness of early recombinant erythropoietin administered to preterm infants by continuous intravenous versus subcutaneous route","author":"Maggio","year":"2007"},{"key":"10.1002\/14651858.CD004863.pub3-BIB40|cit40","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/S0022-3476(98)70320-8","article-title":"High- versus low-dose erythropoietin in extremely low birth weight infants","volume":"132","author":"Maier","year":"1998","journal-title":"Journal of Pediatrics"},{"key":"10.1002\/14651858.CD004863.pub3-BIB41|cit41","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/S0022-3476(96)70363-3","article-title":"Pharmacokinetics and effectiveness of recombinant erythropoietin administered to preterm infants by continuous infusion in total parenteral nutrition solution","volume":"128","author":"Ohls","year":"1996","journal-title":"Journal of Pediatrics"},{"key":"10.1002\/14651858.CD004863.pub3-BIB42|cit42","series-title":"Pediatric Academic Societies' Annual Meeting","first-page":"PAS 2005:57:164","article-title":"Is erythropoietin (EPO) a multifunctional tissue protective cytokine? Follow-up of eHuEPO treated prematures","author":"Soubasi","year":"2005"},{"key":"10.1002\/14651858.CD004863.pub3-BIB43|cit43","series-title":"Pediatric Academic Societies' Annual Meeting","first-page":"E","article-title":"High dose of erythropoietin in premature neonates: Short-term outcomes","author":"Soubasi","year":"2009"},{"key":"10.1002\/14651858.CD004863.pub3-BIB44|cit44","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1055\/s-2005-918888","article-title":"The effect of early recombinant erythropoietin and enteral iron supplementation on blood transfusion in preterm infants","volume":"22","author":"Turker","year":"2005","journal-title":"American Journal of Perinatology"},{"key":"10.1002\/14651858.CD004863.pub3-BIB45|cit45","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/jp.2010.80","article-title":"Comparison between one and three doses a week of recombinant erythropoietin in very low birth weight infants","volume":"31","author":"V\u00e1zquez L\u00f3pez","year":"2011","journal-title":"Journal of Perinatology"},{"key":"10.1002\/14651858.CD004863.pub3-BIB46|cit46","doi-asserted-by":"crossref","first-page":"e218","DOI":"10.1542\/peds.2008-3553","article-title":"Erythropoietin improved neurologic outcomes in newborns with hypoxic-ischemic encephalopathy","volume":"124","author":"Zhu","year":"2009","journal-title":"Pediatrics"},{"issue":"3","key":"10.1002\/14651858.CD004863.pub3-BIB47|cit47","article-title":"Late administration of erythropoietin for preventing red blood cell transfusion in preterm and\/or low birth weight infants","author":"Aher","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD004863.pub3-BIB48|cit48","article-title":"Early versus late erythropoietin for preventing red blood cell transfusion in preterm and\/or low birth weight infants","author":"Aher","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD004863.pub3-BIB49|cit49","series-title":"American Pediatric Societies' Annual Meeting","first-page":"Abstract 2135","article-title":"Erythropoietin treatment and >\/= stage III retinopathy of prematurity in very low birth weight (VLBW) infants","author":"Aulak","year":"2002"},{"key":"10.1002\/14651858.CD004863.pub3-BIB50|cit50","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1542\/peds.2008-0377","article-title":"Using a count of neonatal morbidities to predict poor outcome in extremely low birth weight infants: added role of neonatal infection","volume":"123","author":"Bassler","year":"2009","journal-title":"Pediatrics"},{"key":"10.1002\/14651858.CD004863.pub3-BIB51|cit51","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/jama.1996.03540080059030","article-title":"Improving the quality of reporting of randomized controlled trials. The CONSORT statement","volume":"276","author":"Begg","year":"1996","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD004863.pub3-BIB52|cit52","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/S0022-3476(83)80600-3","article-title":"Postnatal changes in erythropoietin levels in untransfused premature infants","volume":"103","author":"Brown","year":"1983","journal-title":"Journal of Pediatrics"},{"key":"10.1002\/14651858.CD004863.pub3-BIB53|cit53","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S0022-3476(05)82670-8","article-title":"Prediction of the need for transfusion during anemia of prematurity","volume":"116","author":"Brown","year":"1990","journal-title":"Journal of Pediatrics"},{"key":"10.1002\/14651858.CD004863.pub3-BIB54|cit54","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jaapos.2005.09.005","article-title":"Association between higher cumulative doses of recombinant erythropoietin and risk for retinopathy of prematurity","volume":"10","author":"Brown","year":"2006","journal-title":"Journal of the American Association for Pediatric Ophthalmology and Strabismus"},{"key":"10.1002\/14651858.CD004863.pub3-BIB55|cit55","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0095-5108(18)30138-6","article-title":"Transfusion practices in infants receiving assisted ventilation","volume":"25","author":"Cohen","year":"1998","journal-title":"Clinics in Perinatology"},{"key":"10.1002\/14651858.CD004863.pub3-BIB56|cit56","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1146\/annurev.me.32.020181.001043","article-title":"Anemia of prematurity","volume":"32","author":"Dallman","year":"1981","journal-title":"Annual Review of Medicine"},{"key":"10.1002\/14651858.CD004863.pub3-BIB57|cit57","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1159\/000047097","article-title":"The biology of erythropoietin in the central nervous system and its neurotrophic and neuroprotective potential","volume":"79","author":"Dame","year":"2001","journal-title":"Biology of the Neonate"},{"key":"10.1002\/14651858.CD004863.pub3-BIB58|cit58","series-title":"Pediatric Academic Societies' Annual Meeting","first-page":"Abstract 2238","article-title":"Recombinant human erythropoietin (rhEPO): A possible risk factor for retinopathy of prematurity (ROP)","author":"Luca","year":"2001"},{"key":"10.1002\/14651858.CD004863.pub3-BIB59|cit59","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1182\/blood.V60.6.1241.1241","article-title":"Erythropoiesis, erythropoietin and iron","volume":"60","author":"Finch","year":"1982","journal-title":"Blood"},{"key":"10.1002\/14651858.CD004863.pub3-BIB60|cit60","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/sj.jp.7210677","article-title":"Effect of recombinant erythropoietin on \"late\" transfusions in the neonatal intensive care unit: a meta-analysis","volume":"22","author":"Garcia","year":"2002","journal-title":"Journal of Perinatology"},{"issue":"1","key":"10.1002\/14651858.CD004863.pub3-BIB61|cit61","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003061.pub2","article-title":"Iron supplementation for erythropoietin-treated preterm infants (Protocol)","author":"Genen","year":"2001","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD004863.pub3-BIB62|cit62","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s004310050641","article-title":"Blood transfusion. Iron load and retinopathy of prematurity","volume":"156","author":"Hesse","year":"1997","journal-title":"European Journal of Pediatrics"},{"key":"10.1002\/14651858.CD004863.pub3-BIB63|cit63","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD004863.pub3-BIB64|cit64","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. [updated March 2011] The Cochrane Collaboration. Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD004863.pub3-BIB65|cit65","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0045-9380(99)80055-3","article-title":"Erythropoietin in the neonate","volume":"29","author":"Juul","year":"1999","journal-title":"Current Problems in Pediatrics"},{"key":"10.1002\/14651858.CD004863.pub3-BIB66|cit66","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1651-2227.2002.tb02904.x","article-title":"Erythropoietin in the central nervous system, and its use to prevent hypoxic-ischemic brain damage","volume":"91","author":"Juul","year":"2002","journal-title":"Acta Paediatrica Supplement"},{"key":"10.1002\/14651858.CD004863.pub3-BIB67|cit67","volume-title":"Care of the High-risk Neonate (Third edition)","author":"Klaus","year":"1986"},{"key":"10.1002\/14651858.CD004863.pub3-BIB68|cit68","volume-title":"Asistencia del recien nacido de alto riesgo, 3e edicion","author":"Klaus","year":"1987"},{"key":"10.1002\/14651858.CD004863.pub3-BIB69|cit69","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/sj.jp.7211018","article-title":"Effect of beginning recombinant erythropoietin treatment within the first week of life, among very-low-birth-weight neonates, on \"early\" and \"late\" erythrocyte transfusions: a meta-analysis","volume":"24","author":"Kotto-Kome","year":"2004","journal-title":"Journal of Perinatology"},{"key":"10.1002\/14651858.CD004863.pub3-BIB70|cit70","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S0022-3476(95)70561-9","article-title":"Reducing blood donor exposures in low birth weight infants by the use of older, unwashed packed red blood cells","volume":"126","author":"Lee","year":"1995","journal-title":"Journal of Pediatrics"},{"key":"10.1002\/14651858.CD004863.pub3-BIB71|cit71","series-title":"Pediatric Academic Societies' 2006 Annual Meeting. http:\/\/www.abstracts2view.com\/pas\/","first-page":"E","article-title":"High-dose recombinant human erythropoietin may increase the incidence and severity of ROP in premature infants","author":"Liu","year":"2006"},{"key":"10.1002\/14651858.CD004863.pub3-BIB72|cit72","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S0022-3476(00)70105-3","article-title":"Changing practices of red blood cell transfusions in infants with birth weights less than 1000 g","volume":"136","author":"Maier","year":"2000","journal-title":"Journal of Pediatrics"},{"key":"10.1002\/14651858.CD004863.pub3-BIB73|cit73","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1056\/NEJM200511173532015","article-title":"Erythropoietin as a retinal angiogenic factor","volume":"353","author":"Manzoni","year":"2005","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD004863.pub3-BIB74|cit74","series-title":"Pedaitric Academic Societies' Annual Meeting","first-page":"E","article-title":"Use of erythropoietin is associated with threshold retinopathy of prematurity (ROP) in preterm extremely-low-birth-weight neonates: A retrospective, cohort study from two large tertiary NICUs in Italy","author":"Manzoni","year":"2008"},{"key":"10.1002\/14651858.CD004863.pub3-BIB75|cit75","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1093\/emboj\/cdg117","article-title":"HLF\/HIF-2 alpha is a key factor in retinopathy of prematurity in association with erythropoietin","volume":"22","author":"Morita","year":"2003","journal-title":"The EMBO Journal"},{"key":"10.1002\/14651858.CD004863.pub3-BIB76|cit76","series-title":"Pediatric Academic Societies' 2006 Annual Meeting. http:\/\/www.abstracts2view.com\/pas\/","first-page":"E","article-title":"Treatment with erythropoietin and incidence of retinopathy of prematurity in ELBW infants","author":"Musante","year":"2006"},{"key":"10.1002\/14651858.CD004863.pub3-BIB77|cit77","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0095-5108(05)70045-2","article-title":"The use of erythropoietin in neonates","volume":"27","author":"Ohls","year":"2000","journal-title":"Clinics in Perinatology"},{"key":"10.1002\/14651858.CD004863.pub3-BIB78|cit78","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1067\/mpd.2002.125853","article-title":"Erythropoietin treatment in extremely low birth weight infants: blood in versus blood out","volume":"141","author":"Ohls","year":"2002","journal-title":"Journal of Pediatrics"},{"key":"10.1002\/14651858.CD004863.pub3-BIB79|cit79","series-title":"Pediatric Academic Societies' Annual Meeting","first-page":"E","article-title":"Effect of erythropoietin (EPO) on neurodevelopmental outcomes and retinopathy of prematurity (ROP) in extremely low birth weight infants","author":"Rangaswamy","year":"2011"},{"key":"10.1002\/14651858.CD004863.pub3-BIB80|cit80","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) Version 5.1 2011"},{"key":"10.1002\/14651858.CD004863.pub3-BIB81|cit81","first-page":"83","article-title":"Treatment with human recombinant erythropoietin and frequency of retinopathy of prematurity","volume":"59 Supplement 1","author":"Rudzinska","year":"2002","journal-title":"Przeglad Lekarski"},{"key":"10.1002\/14651858.CD004863.pub3-BIB82|cit82","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1001\/jama.289.9.1124","article-title":"Impact of bronchopulmonary dysplasia, brain injury, and severe retinopathy on the outcome of extremely low-birth-weight infants at 18 months: results from the trial of indomethacin prophylaxis in preterms","volume":"289","author":"Schmidt","year":"2003","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD004863.pub3-BIB83|cit83","series-title":"Pediatric Academic Societies Annual Meeting","first-page":"57;546","article-title":"Effect of recombinant human erythropoietin (rhEPO) on the development of retinopathy of prematurity (ROP)","author":"Shah","year":"2005"},{"key":"10.1002\/14651858.CD004863.pub3-BIB84|cit84","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1055\/s-0029-1224872","article-title":"The effect of recombinant human erythropoietin on the development of retinopathy of prematurity","volume":"27","author":"Shah","year":"2010","journal-title":"American Journal of Perinatology"},{"key":"10.1002\/14651858.CD004863.pub3-BIB85|cit85","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1542\/peds.95.1.1","article-title":"Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birth weight preterm infants","volume":"95","author":"Shannon","year":"1995","journal-title":"Pediatrics"},{"key":"10.1002\/14651858.CD004863.pub3-BIB86|cit86","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0308-2261(21)00567-1","article-title":"Physiological anaemia of infancy and the anaemia of prematurity","volume":"7","author":"Stockman","year":"1978","journal-title":"Clinics in Hematology"},{"key":"10.1002\/14651858.CD004863.pub3-BIB87|cit87","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0031-3955(16)34972-0","article-title":"Anemia of prematurity. Current concept in the issue of when to transfuse","volume":"33","author":"Stockman","year":"1986","journal-title":"Pediatric Clinics of North America"},{"key":"10.1002\/14651858.CD004863.pub3-BIB88|cit88","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1423-0410.1986.tb00201.x","article-title":"Current issues in neonatal transfusions","volume":"51","author":"Strauss","year":"1986","journal-title":"Vox Sanguinis"},{"key":"10.1002\/14651858.CD004863.pub3-BIB89|cit89","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1046\/j.1537-2995.2001.41030406.x","article-title":"Meta-analysis of controlled clinical trials studying the efficacy of rHuEPO in reducing blood transfusions in the anemia of prematurity","volume":"41","author":"Vamvakas","year":"2001","journal-title":"Transfusion"},{"key":"10.1002\/14651858.CD004863.pub3-BIB90|cit90","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1056\/NEJMoa041773","article-title":"Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy","volume":"353","author":"Watanabe","year":"2005","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD004863.pub3-BIB91|cit91","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/S0022-3476(96)70150-6","article-title":"Changing patterns of red blood cell transfusion in very low birth weight infants","volume":"129","author":"Widness","year":"1996","journal-title":"Journal of Pediatrics"},{"issue":"2","key":"10.1002\/14651858.CD004863.pub3-BIB92|cit92","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD008316","article-title":"Erythropoietin for term and late preterm infants with hypoxicischemic encephalopathy","author":"Yu","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD004863.pub3-BIB93|cit93","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1203\/00006450-200008000-00002","article-title":"Erythropoietin therapy for premature infants: cost without benefit?","volume":"48","author":"Zipursky","year":"2000","journal-title":"Pediatric Research"},{"issue":"3","key":"10.1002\/14651858.CD004863.pub3-BIB94|cit94","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004863.pub2","article-title":"Early erythropoietin for preventing red blood cell transfusion in preterm and\/or low birth weight infants","author":"Ohlsson","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"}],"updated-by":[{"DOI":"10.1002\/14651858.cd004863.pub4","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2014,4,26]],"date-time":"2014-04-26T00:00:00Z","timestamp":1398470400000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD004863.pub3\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T05:09:14Z","timestamp":1643346554000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD004863.pub3"}},"subtitle":[],"editor":[{"given":"Arne","family":"Ohlsson","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2012,9,12]]},"references-count":94,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd004863.pub3","relation":{"new_version":[{"id-type":"doi","id":"10.1002\/14651858.CD004863.pub4","asserted-by":"object"}]},"subject":[],"published":{"date-parts":[[2012,9,12]]}}}